MabSpace Biosciences Overview
- Year Founded
-
2012

- Status
-
Acquired/Merged
- Employees
-
60

- Latest Deal Type
-
Merger of Eq.
MabSpace Biosciences General Information
Description
Developer of antibody based therapeutics designed to treat cancer and fibrotic disorders affecting lung, kidney and liver. The company's therapeutics are based on its proprietary immune tolerance breaking technology (IMBT) that generates lead antibodies with diverse epitopes that targets different components of the tumor microenvironment, enabling physicians to treat cancer and fibrotic diseases with a better medical outcome.
Contact Information
Website
www.mabspacebio.comCorporate Office
- Room B6-501, Bio-Nano Park
- No.218 Xinghu Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
Corporate Office
- Room B6-501, Bio-Nano Park
- No.218 Xinghu Street, Suzhou Industrial Park
- Suzhou, Jiangsu 215123
- China
MabSpace Biosciences Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger of Equals | 02-Jan-2019 | Completed | Generating Revenue | |||
2. Early Stage VC (Series B1) | 09-Feb-2018 | Completed | Generating Revenue | |||
1. Early Stage VC (Series A2) | 28-Aug-2015 | $13M | $13M | Completed | Generating Revenue |
MabSpace Biosciences Comparisons
Industry
Financing
Details
MabSpace Biosciences Competitors (90)
One of MabSpace Biosciences’s 90 competitors is Gadeta, a Formerly VC-backed company based in Utrecht, Netherlands.
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Gadeta | Formerly VC-backed | Utrecht, Netherlands | ||||
Repertoire Immune Medicines | Venture Capital-Backed | Cambridge, MA | ||||
NexImmune | Formerly VC-backed | Gaithersburg, MD | ||||
Iovance Biotherapeutics | Corporation | San Carlos, CA | ||||
Intensity Therapeutics | Formerly PE-Backed | Shelton, CT |
MabSpace Biosciences Signals
MabSpace Biosciences Former Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Hongshan Capital Group | Venture Capital | Minority | ||
King Star Capital | Venture Capital | Minority | ||
Lilly Asia Ventures | Corporate Venture Capital | Minority | ||
Teng Yue Partners | Hedge Fund | Minority |
MabSpace Biosciences FAQs
-
When was MabSpace Biosciences founded?
MabSpace Biosciences was founded in 2012.
-
Where is MabSpace Biosciences headquartered?
MabSpace Biosciences is headquartered in Suzhou, China.
-
What is the size of MabSpace Biosciences?
MabSpace Biosciences has 60 total employees.
-
What industry is MabSpace Biosciences in?
MabSpace Biosciences’s primary industry is Drug Discovery.
-
Is MabSpace Biosciences a private or public company?
MabSpace Biosciences is a Private company.
-
What is MabSpace Biosciences’s current revenue?
The current revenue for MabSpace Biosciences is
. -
How much funding has MabSpace Biosciences raised over time?
MabSpace Biosciences has raised $53M.
-
Who are MabSpace Biosciences’s investors?
Hongshan Capital Group, King Star Capital, Lilly Asia Ventures, and Teng Yue Partners have invested in MabSpace Biosciences.
-
Who are MabSpace Biosciences’s competitors?
Gadeta, Repertoire Immune Medicines, NexImmune, Iovance Biotherapeutics, and Intensity Therapeutics are some of the 90 competitors of MabSpace Biosciences.
-
When was MabSpace Biosciences acquired?
MabSpace Biosciences was acquired on 02-Jan-2019.
-
Who acquired MabSpace Biosciences?
MabSpace Biosciences was acquired by Transcenta Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »